LifeTech Scientific Corporation (stock code: 01302) has announced that its board of directors will convene on Tuesday, 31 March 2026.

The meeting agenda includes:

1. Reviewing and approving the audited consolidated results for the financial year ended 31 December 2025 and authorising their publication on the websites of Hong Kong Exchanges and Clearing Limited and the company.

2. Considering the recommendation of a final dividend.

3. Deliberating the potential closure period for the register of members.

4. Setting the date, time and venue for the forthcoming annual general meeting.

5. Addressing any other business matters.

The notice is issued by Executive Director, Chairman and Chief Executive Officer Mr. Xie Yuehui on behalf of the board, which currently comprises five executive directors, one non-executive director and two independent non-executive directors.